Dramatic response to brentuximab vedotin in refractory nontransformed CD 30 – mycosis fungoides allowing allogeneic stem cell transplant and long‐term complete remission-Reference-Cited by-同舟云学术

Dramatic response to brentuximab vedotin in refractory nontransformed CD 30 – mycosis fungoides allowing allogeneic stem cell transplant and long‐term complete remission

Published:2019-06 Issue:6 Volume:180 Page:1517-1520
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Mahévas T.¹^ORCID,Ram‐Wolff C.¹,Battistella M.²³,Pennamen M.D.V.²,Rivet J.²,Brice P.³⁴,Bagot M.¹³

Affiliation:

1. Department of Dermatology AP‐HP Hôpital Saint‐Louis ParisFrance

2. Department of Pathology AP‐HP Hôpital Saint‐Louis ParisFrance

3. Sorbonne Paris Cité Université Paris Diderot Paris France

4. Department of Hematology AP‐HP Hôpital Saint‐Louis Paris France

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17254

Reference12 articles.

1. Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

2. Fatal Cytotoxic Cutaneous Lymphoma Presenting as Ulcerative Psoriasis

3. Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome

4. Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009

5. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Syndrome de Sézary;Hématologie;2024-01-01

2. Indolente kutane T-Zell-Lymphome;Indolente Lymphome;2023

3. Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry;Journal of the European Academy of Dermatology and Venereology;2022-09-09

4. Special clinicopathological features of anaplastic diffuse large B-cell lymphoma: a case report and literature review;2022-09-06

5. New biotherapies for the treatment of cutaneous T-cell lymphomas;La Presse Médicale;2022-03